These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
812 related articles for article (PubMed ID: 28050648)
1. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients. Zhu L; Li C; Liu N; Yang X; Jia RL; Mu R; Su Y; Li ZG Clin Rheumatol; 2017 Feb; 36(2):401-406. PubMed ID: 28050648 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome. Zhang S; Wu Z; Zhang W; Zhao J; Norman GL; Zeng X; Zhang F; Li Y Clin Chem Lab Med; 2018 May; 56(6):939-946. PubMed ID: 29561729 [TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
4. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome. Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605 [TBL] [Abstract][Full Text] [Related]
5. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Vandevelde A; Chayoua W; de Laat B; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ J Thromb Haemost; 2022 Sep; 20(9):2136-2150. PubMed ID: 35713971 [TBL] [Abstract][Full Text] [Related]
6. Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity. Zhang Y; Su Y; Guo H; Wang L; Li A; Wang C; Zhang J; Qiao R Clin Biochem; 2023 Feb; 112():17-23. PubMed ID: 36535385 [TBL] [Abstract][Full Text] [Related]
7. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort. Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978 [TBL] [Abstract][Full Text] [Related]
8. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Vandevelde A; Gris JC; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ J Thromb Haemost; 2023 Jul; 21(7):1981-1994. PubMed ID: 37061133 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant. Bertolaccini ML; Sciascia S; Murru V; Garcia-Fernandez C; Sanna G; Khamashta MA Thromb Haemost; 2013 Feb; 109(2):207-13. PubMed ID: 23254928 [TBL] [Abstract][Full Text] [Related]
10. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348 [TBL] [Abstract][Full Text] [Related]
11. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome. Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262 [TBL] [Abstract][Full Text] [Related]
12. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk. Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E Front Immunol; 2021; 12():754469. PubMed ID: 34790198 [TBL] [Abstract][Full Text] [Related]
13. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome]. Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574 [TBL] [Abstract][Full Text] [Related]
14. Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome. Hoxha A; Mattia E; Tonello M; Grava C; Pengo V; Ruffatti A Clin Chem Lab Med; 2017 May; 55(6):890-898. PubMed ID: 27816952 [TBL] [Abstract][Full Text] [Related]
15. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome. Kopytek M; Natorska J; Undas A Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587 [TBL] [Abstract][Full Text] [Related]
16. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome. Vlagea A; Gil A; Cuesta MV; Arribas F; Diez J; Lavilla P; Pascual-Salcedo D Clin Appl Thromb Hemost; 2013 Jun; 19(3):289-96. PubMed ID: 22387581 [TBL] [Abstract][Full Text] [Related]
17. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements. Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654 [TBL] [Abstract][Full Text] [Related]
18. Antibody profiles for the diagnosis of antiphospholipid syndrome. Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401 [TBL] [Abstract][Full Text] [Related]